CXCR5 is a very promising drug target for the development of antibody-drug conjugates to treat patients with lymphoma Tibor Schomber,Beatrix Stelte-Ludwig, Amy J. Johnson,Oliver von Ahsen,Christoph Schatz,Raquel Izumi,Ahmed Hamdy,Hans-Georg LerchenCANCER RESEARCH(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要